Healthcare >> CEO Interviews >> December 7, 2009
CHRISTOPHER M. CASHMAN joined SANUWAVE as a member of the board of directors and as President and Chief Executive Officer in December 2005. Immediately prior, he served as President of Therapeutic Surfaces for Kinetic Concepts, Inc, a global leader in advanced wound care. He conducted a management buyout in November 2001 of Snowden Pencer, a minimally invasive surgical device manufacturer, and assumed the role of CEO and President. In March 2004, Snowden Pencer was sold to Cardinal Health. Mr. Cashman has also served as a Business Unit Head with Genzyme Biosurgery, and held several senior sales and marketing positions with Genzyme Surgical Products and Deknatel Snowden Pencer. Mr. Cashman graduated from the United States Naval Academy in 1989 with a B.S. in economics and served on a fast-attack submarine as Supply Officer. He received his MBA degree in 2001 from The Kellogg School of Management at Northwestern University. Profile
TWST: Let's begin with some background on SANUWAVE, a picture of what the company is doing now, your operations, products, etc.
Mr. Cashman: SANUWAVE (SNWV.OB) is an emerging leader in the
